Article · Journal · 2026

Design and in silico optimization of pyrazolopyridine-based pantothenate synthetase (PanC) inhibitors as novel anti-tuberculosis leads

Current Pharmaceutical Analysis

Citations: 0from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 46th percentileby citations, against works of its field and year
Authors: 6from 3 institutions

Authors

6 authors across 3 institutions in 2 countries